Dr. Octavio Cieza, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 507 N Brightleaf Blvd Ste 201, Smithfield, NC 27577 Phone: 919-934-8544 Fax: 919-934-8738 |
News Archive
Depomed, Inc. today announced that it has received a $10 million milestone payment from Abbott Products, Inc., its licensee of DM-1796, for the U.S. Food and Drug Administration's acceptance for filing of the New Drug Application (NDA) for DM-1796 for the management of postherpetic neuralgia (PHN), or pain after shingles.
Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce it has signed a lease for a new corporate headquarters as its new base of operations in Denver, Colorado. The 6,600 sq. ft. core facility at 2422 S. Trenton Way, Unit H will be dedicated to housing executive offices, administrative personnel, as well as the Lab Division core of operations for its cannabis formulations testing and FDA initiatives.
A team of researchers led by Andrew Coop, PhD, professor and chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy, has developed a new opioid drug that shows great potential to advance treatment and improve quality of life for individuals living with chronic pain.
BioDelivery Sciences International, Inc. today announced the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain.
California-based HMO Kaiser Permanente on Wednesday announced the creation of a decades-long research project that will collect and analyze genetic information from hundreds of thousands of adult members, the San Jose Mercury News reports.
› Verified 3 days ago